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Background: Phosphatase and tensin homolog (PTEN)
mediates many of its effects on proliferation, growth,
survival, and migration through its PtdIns(3,4,5)P3 lipid
phosphatase activity, suppressing phosphoinositide
3-kinase (PI3K)-dependent signaling pathways. PTEN
also possesses a protein phosphatase activity, the role
of which is less well characterized.
Results: We have investigated the role of PTEN in the
control of cell migration of mesoderm cells ingressing
through the primitive streak in the chick embryo. Over-
expression of PTEN strongly inhibits the epithelial-
to-mesenchymal transition (EMT) of mesoderm cells
ingressing through the anterior and middle primitive
streak, but it does not affect EMT of cells located in
the posterior streak. The inhibitory activity on EMT is
completely dependent on targeting PTEN through its
C-terminal PDZ binding site, but can be achieved by
a PTEN mutant (PTEN G129E) with only protein phos-
phatase activity. Expression either of PTEN lacking the
PDZ binding site or of the PTEN C2 domain, or inhibition
of PI3K through specific inhibitors, does not inhibit
EMT, but results in a loss of both cell polarity and direc-
tional migration of mesoderm cells. The PTEN-related
protein TPTE, which normally lacks any detectable lipid
and protein phosphatase activity, can be reactivated
through mutation, and only this reactivated mutant
leads to nondirectional migration of these cells in vivo.
Conclusions: PTEN modulates cell migration of meso-
derm cells in the chick embryo through at least two
distinct mechanisms: controlling EMT, which involves
its protein phosphatase activity; and controlling the
directional motility of mesoderm cells, through its lipid
phosphatase activity.
Introduction
PTEN is one of the most frequently lost tumor sup-
pressors in human cancers and has been shown to
have many diverse effects on cellular behavior, acting
in many cell types to inhibit cellular survival, growth,
and motility [1–3]. PTEN is a lipid phosphatase that
acts through metabolism of PtdIns(3,4,5)P3 to inhibit
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upon this second messenger. As part of the PI3K/Akt sig-
naling pathway, PtdIns(3,4,5)P3 is recognized to play an
important role in the regulation of many cellular pro-
cesses that are antagonized by PTEN, including prolifer-
ation, growth and survival, and migration [2]. Thus, it
seems clear that many of the effects of PTEN on cellular
behavior are largely mediated through regulation of
PtdIns(3,4,5)P3-dependent signaling. However, other
potential mechanisms of action of PTEN have been iden-
tified, including the activity of the phosphatase against
protein substrates [4] and also a phosphatase-indepen-
dent capability to inhibit cell migration in a scratch-
wound assay, an inhibition mediated by the C2 domain
of PTEN [5]. Although the physiological significance of
PtdIns(3,4,5)P3-independent effects of PTEN is contro-
versial [6–9], much of the evidence supporting a physio-
logical role for the PtdIns(3,4,5)P3-independent activity
of PTEN has come from studies of cell motility. Recent
work confirmed the findings [8, 10, 11] that PTEN
G129E, lacking PtdIns(3,4,5)P3 phosphatase activity,
could inhibit cell motility as efficiently as the wild-type
enzyme, when expressed through microinjection of ex-
pression constructs into PTEN null glioblastoma cells
[5]. This study went on to show that this property could
be seen also through expression of only the C2 domain
of PTEN, and it implicated the protein phosphatase ac-
tivity of PTEN in autodephosphorylation of the inhibitory
phosphorylation sites in the C terminus of PTEN [5].
A role for PTEN in the control of cell polarization has
been well documented during chemotaxis of Dictyoste-
lium up a cAMP gradient. Deletion of PTEN results in
increased and spatially extended PtdIns(3,4,5)P3 pro-
ductionat the leadingedgeofcellsmigrating inagradient
of cAMP [12, 13]. This increased PtdIns(3,4,5)P3 domain
results in defective polarization of the cells in the direc-
tion of the gradient [12, 13]. In zebrafish embryos, PI3K
activity has been implicated in the directional migration
of invaginating mesoderm cells toward the anterior,
where inhibition of PI3K results in loss of polarity and
reduced migration speed [14]. In mice, deletion of PTEN
results in lethality at the early stages of gastrulation
before somitogenesis [15], but the detailed effects on dif-
ferentiation and migration of cells have not been identi-
fied. Studies of mouse embryonic fibroblasts (MEFs)
and B lymphocytes lacking the PTEN gene have found
that these cells migrate faster than wild-type counter-
parts in culture, indicating a physiological role for PTEN
in the suppression of cell motility [6, 16]. Re-expression
of PTEN in mammalian cells lacking the enzyme has
been found to inhibit the motility of several lineages of
such cells, including mouse embryo fibroblasts and
tumor-derived cells of glial, prostate, and T cell origin
[6, 8, 17, 18], although most of these studies have not
addressed the mechanism of action of PTEN.
We chose to address the effect of overexpression of
PTEN in mesoderm cells destined to become somites,
migrating away from the primitive streak of a developing
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116Figure 1. PTEN Inhibits the Outward Migration of Primitive-Streak Cells during Chick Embryogenesis
(A–E) Analysis of endogenous-PTEN expression in the stage 4 (HH4) chick embryo. (A) and (B) show in situ hybridization for PTEN mRNA. (C)–(E)
show immunostaining for PTEN protein. Sections of the embryos as indicated by a dashed white line in (A) and (C) are shown in (B) and (D).
(F) Cartoon of the chick-embryo migration assay. Stage 4 (HH4) Chick embryos are transfected with expression vectors encoding the green fluo-
rescent protein (GFP) or a GFP fusion protein. Transfected primitive-streak pieces (in this case, anterior streak) were grafted to replace primitive-
streak tissue in an untransfected host embryo, after which development was observed by bright-field and fluorescence time-lapse microscopy.
(G) The overexpression of GFP-PTEN in transfected embryos is shown by western blotting for PTEN with the pooled protein from four dissected
primitive-streak fragments, immediately before and 18 hr after transfection.
(H–K) Migration of anterior-streak cells expressing GFP (H), wild-type GFP-PTEN fusion protein (I), GFP-PTEN C124S (phosphatase dead) (J),
and GFP-PTEN G129E (lipid phosphatase activity dead, protein phosphatase activity retained) (K) was observed over 24 or 30 hr as indicated.
Initial (t = 0) and final (t = 24 hr or 30 hr) images are shown of the migration assay merging bright-field and fluorescent images, allowing the
outward migration of green fluorescently marked cells to be observed. Note that in the GFP control and GFP PTEN C124S experiments, trans-
fected anterior-streak cells have moved out of the streak and aligned themselves on both sides of the embryo’s midline in the forming somites.
The cells expressing the GFP-PTEN wt or G129E constructs have failed to migrate out of the streak.chick embryo. The migration of these cells has been
shown to be controlled by chemoattractant and repel-
lent responses to FGF4 and FGF8, respectively [19]. In
the current experiments, the migration of primitive-
streak cells transfected with green fluorescent protein
(GFP) fusion proteins with PTEN and several PTEN
mutants was followed over time by using fluorescence
time-lapse microscopy, allowing a detailed character-
ization of the migration behavior of these cells and the
demonstration that PTEN has two separable mechanism
of action in this assay.
Results
Inhibition of Migration by PTEN
We addressed the effects of phosphatase and tensin
homolog (PTEN) expression upon the outward migrationof cells from the anterior primitive streak during chick-
embryo development (Figure 1 and Movie S1 in the Sup-
plemental Data available online). In this assay, an em-
bryo is transfected by electroporation and a graft of
transfected cells from the primitive streak is made into
an untransfected host embryo before the outward mi-
gration of these labeled cells is observed by timelapse
fluorescence microscopy. In these experiments, overex-
pression of either PTEN or a GFP-PTEN fusion protein
caused a dramatic inhibition of the migration of trans-
fected anterior primitive-streak cells away from the
primitive streak, contrasting with cells transfected with
GFP alone. Anterior-streak cells transfected with GFP
alone show a typical initial outward migration of the cells
away from the streak, followed by a phase of migration
back toward the midline after the regression process
starts, as described before (Figure 1H, Figure S1A, and
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117Figure 2. Expression of GFP-PTEN G129E Blocks EMT
Cells of the primitive streak were transfected with vectors encoding either GFP (A, C, E, G, and I) or GFP-PTEN G129E (B, D, F, H, and J) before
grafting into an untransfected host embryo. Development was allowed to proceed for 15 hr before analysis.
(A and B) Overview images showing migration of the cells away from the streak when expressing GFP (A) and no migration when the cell express
GFP-PTEN G129E (B).
(C–J) High-magnification images of the grafted cells expressing GFP (C, E, G, and I) or GFP-PTEN G129E (D, F, H, and J). Transfected cells are
green, and the expression— detected by antibody staining—of endogenous b-Catenin (C–F) and E-cadherin (G–J) is shown in red.
The scale bars represent 1 mm in (A), 50 mm in (C) and (G), and 20 mm in (E) and (I). Expression of wild-type PTEN had the same effect in these
experiments as PTEN G129E.[19]). Anterior-streak cells overexpressing PTEN do not
move out of the graft (Figure1I and Figure S1B).
Analysis of the expression of endogenous PTEN
mRNA and protein by in situ hybridization and immu-
nofluorescence, respectively, was performed in the
developing chick embryo (Figure 1 and Figure S2). This
showed very low expression levels early in development,
but increasing levels during Hamburger and Hamilton
(HH) stages 3–8, especially in the epiblast and primitive
streak. Interestingly, PTEN protein appeared to be
localized close to the apical membrane in epiblast cell
sections, but at the cell periphery when observed from
above, consistent with an enrichment at adherens
junctions (see Figures 1D and 1E) [20, 21]. Western-blot
analysis of transfected embryos shows that the PTEN
transgene is expressed very strongly (Figure 1G).
PtdIns(3,4,5)P3 Phosphatase Activity Is Not Required
for the Inhibition of Cell Migration out of the Streak
by PTEN
The reliance of the PTEN effects upon phosphatase
activity was investigated by expression of the active-site mutants PTEN C124S, which lacks all detectable
phosphatase activity, and PTEN G129E, which has dra-
matically impaired lipid phosphatase activity but retains
full protein phosphatase activity [22]. These experi-
ments showed that PTEN C124S did not inhibit cell mi-
gration out of the streak and that the migration patterns
of the cells that moved out were normal (Figure 1J and
Figure S6A). Contrary to this, expression of PTEN
G129E inhibited migration as efficiently as the wild-
type protein. Transfected cells failed to migrate out of
the streak (Figure 1K and Figure S6B), implying that
the lipid phosphatase activity is not required for the
inhibition of cell migration out of the streak.
Cells of the developing primitive streak undergo an
epithelial-to-mesenchymal transition (EMT) before mi-
grating away from the streak ([23, 24] and Figure 2). In
contrast, cells expressing either wild-type PTEN or
PTEN G129E did not undergo an EMT. The cells ap-
peared to be highly adhesive, did not integrate properly
into the streak, stayed strongly compacted, and did not
downregulate E-cadherin or b-catenin, as judged by
retained immunoreactivity for these molecules at the
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118Figure 3. The Migration Inhibition Caused by
PTEN Is Specific to Cells of the Anterior Prim-
itive Streak and Requires Targeting
Cells grafted in the anterior streak (right) and
posterior streak (left) migrate when express-
ing GFP (A and B), but only cells in the poste-
rior streak migrate away from the streak when
expressing PTEN G129E, whereas the migra-
tion of anterior-streak cells away from the
streak is inhibited (C and D). (A and C) show
fluorescence images taken 15 hr after graft-
ing. (B and D) show cell-track images depict-
ing the migration paths of the cells during the
15 hr of the experiment. (E and F) show migra-
tion of anterior-streak cells expressing
GFP-PTEN DPDZ (E) or GFP-PTEN G129E
DPDZ (F) as indicated. It can be seen that
in both cases, cells can migrate away from
the streak, but that the migration of the cells
expressing GFP-PTEN DPDZ is less direc-
tional (E0) than that of cells expressing GFP-
PTEN G129E DPDZ (F0). Initial (t = 0) and final
(t = 24 hr) images of the cell migration assay
are shown; merging bright-field and fluores-
cent images allows the migration of green
fluorescent cells to be observed in the con-
text of the embryo.cell periphery, relative to cells expressing GFP (Figure 2
and data not shown). As a result, the cells were unable to
migrate away from the streak (Figures 1 and 2 and
Figures S1 and S6). Interestingly, these experiments
suggested that the EMT of both transfected and adja-
cent untransfected cells in the grafted tissue might be
suppressed, indicating that secondary non-cell-autono-
mous effects on EMT may exist in this circumstance
(Figures 2D, 2F, 2H, and 2J). Surprisingly, further exper-
iments showed that, although the expression of wild-
type or G129E PTEN strongly inhibited the migration of
cells away from the anterior and middle streak, it had
a much less pronounced effect on the migration of pos-
terior cells, which were perfectly able to migrate out of
the streak (Figures 3A–3D and data not shown). In the
case of the G129E mutant, these posterior cells migrated
relatively normally to the periphery of the embryo, sug-
gesting that the protein phosphatase activity does not
inhibit cell migration. Expression of wild-type PTEN in
posterior-streak cells did not block the escape of cells
from the streak, but resulted in aberrant directional mi-
gration, suggesting that the lipid phosphatase activity
of PTEN is required to perturb directional migration of
posterior-streak cells (see Movie S1).In order to address the function of the endogenous
PTEN protein in this context, RNA-based knockdown
of PTEN expression was performed. When transfected
into one half of an embryo, this was found to reduce en-
dogenous PTEN RNA and protein levels and increase
phosphorylation of the downstream kinase Akt/PKB
after approximately 20 hr compared to the untransfected
half of the embryo (Figures S3 and S4). PTEN siRNA
transfection also appeared to enhance the expression
of beta-catenin at the cell periphery in transfected epi-
blast cells (Figure S4). When PTEN siRNA was cotrans-
fected with GFP in a standard transfected-graft experi-
ment, this had little effect on the escape of cells from
the transfected primitive-streak graft (Figure S5B). How-
ever, it seems likely that this is because PTEN knock-
down was not complete, with protein levels falling only
slowly over a period of around 20 hr, and that cells
escaped from the primitive-streak graft when PTEN ex-
pression was still high. Therefore, experiments were
performed in which PTEN siRNA was transfected and
cell migration was observed in this transfected embryo
without grafting (Figure S5D). In this case, the most lat-
eral transfected epiblast cells continue to move toward
the streak for many hours after siRNA transfection,
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accumulation of cells in the primitive streak was later ob-
served, although this was not seen in control embryos
(Figure S5). Furthermore, regression of the node was in-
hibited, presumably because not enough cells migrate
out of the streak, and development was impaired.
The extreme C terminus of PTEN contains a PDZ-
domain binding sequence, which is required for the
interaction of the phosphatase with several PDZ-
domain-containing proteins. Although the role of PDZ-
domain-dependent targeting in PTEN function is rather
unclear, it is known that the PDZ binding sequence
is not required for the general regulation of cellular
PtdIns(3,4,5)P3 levels and PKB/Akt activity ([25, 26] and
confirmed during this study [data not shown]). Therefore,
we tested a PTEN mutant lacking the last five C-terminal
amino acids including the PDZ binding sequence, PTEN
DPDZ, in the chick-embryo migration assay. Despite its
ability to regulate cellular PtdIns(3,4,5)P3 levels [26, 27],
and despite its retention of catalytic activity in vitro
([26] and Figure S10), PTEN DPDZ failed to mediate any
detectable effect on the escape of cells from the primitive
streak (Figure 3). We noted, however, that although the
cells are able to undergo EMT, they displayed aberrant
directional migration. This indicates that at least in this
assay, the PtdIns(3,4,5)P3 phosphatase activity may
control the directionality of migration. Expression of
the PTEN G129E DPDZ mutant did not inhibit EMT, and
it allowed normal directional migration of the mesoderm
cells (Figure 3F). The fact that PTEN DPDZ, which has
both lipid and protein phosphatase activity, interferes
with directional migration, but expression of PTEN
G129E DPDZ, which has only a protein phosphatase ac-
tivity, does not, suggests that it is specifically the lipid
phosphatase activity of PTEN that interferes with direc-
tional migration when overexpressed.
Overexpression of PTEN is expected to result in re-
duced cellular PtdIns(3,4,5)P3 levels, and some of the
effects described above, such as the random migration
of posterior-streak cells, might be attributed to reduced
PtdIns(3,4,5)P3 levels. To investigate the effect of low
PtdIns(3,4,5)P3 levels, we measured the migration of
posterior- and middle-streak cells out of the primitive
streak in the presence of the phosphoinositide 3-kinase
(PI3K) inhibitors LY294002 and PI103 [28]. Both inhibi-
tors showed no detectable effect on the escape of cells
from the primitive streak, supporting the above conclu-
sions that EMT is not a PtdIns(3,4,5)P3-dependent pro-
cess. There was, however, a strong effect on directional
migration of both middle- and posterior-primitive-streak
cells; in the presence of the inhibitors, this directional
migration appeared essentially random (Figures 4A–4D
and Movie S1). Observation of the migrating cells at
higher magnification revealed that cells in the presence
of the inhibitor were much more rounded and extended
far fewer filopodia and lamellopodia than cells migrating
in a control embryo (Figures 4E00 and 4F00). The latter
extended many filopodia in the direction of migration,
reinforcing the finding that PtdIns(3,4,5)P3 has an impor-
tant role in cell polarization and directional movement.
In order to ensure that the mutations of PTEN used did
not have any unexpected effects on protein phospha-
tase activity, we tested the PTEN mutants C124S,
G129E, and DPDZ against both the lipid substratePtdIns(3,4,5)P3 and the phosphotyrosine peptide
polymer poly-Glu-Tyr(P). These assays showed that
deletion of the PDZ binding site did not affect the
activity of PTEN in these assays, and they supported
the previous data regarding the phosphatase-dead
(C124S) and protein-phosphatase-only (G129E) mutants
(Figure S10).
The Role of the C2 Domain and C-Terminal Tail
in the Inhibition of Migration
Recent work identified a novel mechanism of action of
PTEN in the cell-migration inhibition, mediated by the
C2 domain of PTEN [5]. Significantly, for this effect of
the C2 domain to be revealed in the full-length protein,
the protein phosphatase activity of PTEN was required,
apparently to mediate autodephosphorylation of the in-
hibitory C-terminal phosphorylation sites, particularly
Thr383. We tested this effect in the mesoderm migration
assay and found that overexpression of a protein con-
taining the C2 domain plus the C-terminal tail of PTEN
(aa 182–403) led to a strong inhibition of EMT, similar
to that seen through the expression of PTEN G129E
(Figures 5B and 5C). This was completely dependent
on the expression of the PDZ binding domain because
the construct lacking this (C2 + tail DPDZ, aa 182–398)
failed to inhibit the exit of cells from the primitive streak,
but severely impaired the directional migration of the
cells (see below).
These data together led to the idea that the observed
inhibition of EMT could result from a dominant-negative
effect of the PDZ-binding-site-containing tail domain.
To test this directly, we studied the expression of the
tail domain by itself and found that expression of this
domain (aa 353–403) also inhibited EMT completely (Fig-
ures 5F, 5G, and 5J–5L). Although the PTEN C124S
mutant did not inhibit EMT or cell migration, we found
that the lack of inhibition of EMT by the phosphatase-
dead PTEN C124S protein could be partially recovered
by mutation of the C-terminal phosphorylation sites (Ta-
ble S1), which may result in the protein’s unfolding and
exposure of the C2 domain and C-terminal tail or PDZ
binding site as previously proposed [5, 29]. These data
together support the proposal that autodephosphoryla-
tion of PTEN is required in order for the C terminus to
inhibit migration [5]. However, we find no evidence for
the specific significance of Thr383, and our data indicate
a novel dominant effect of the C-terminal tail on EMT, in
addition to effects of the C2 domain on directional
migration as identified in the migration of glioblastoma
cells [5]. The directional-impairment effect caused by
the expression of PTEN C2 + tail DPDZ in the chick em-
bryo was shared by the naked PTEN C2 domain and the
C2 domains from both the PTEN-related protein TPTE
(see below) and Dictyostelium PTEN (Figure 5 and
Figure S7). The inhibition of directional migration
strongly resembled that seen in the presence of the
PI3K inhibitors LY294002 and PI103.
Given that the PTEN C2 domain lacks recognized cat-
alytic or protein interaction motifs, it is not clear how
alone it would act to inhibit cell migration. The most
likely regions of the domain to be effector motifs would
seem to be the extended loops, the long unstructured D
loop, and the polybasic CBR3 and Ca2 loops, which
have been shown to play a role in membrane interaction
Current Biology
120Figure 4. PI3-Kinase Inhibitors Do Not Affect Migration of Cells away from the Primitive Streak, but Interfere with Directional Cell Migration and
Cell Polarity
(A and C) Fluorescent images of the migration of anterior- and posterior-streak cells in the absence (A) or presence (C) of the PI3K inhibitor
LY294002 (50 mM) after 1 and 14 hr of migration.
(B and D) The cells tracks of the experiments shown in (A) and (C).
(E and F) the morphology of cells after 14 hr of migration in the presence (E) or absence (F) of 50 mM LY294002. Cells in the presence of the
inhibitor (E) show a rounded morphology compared to control cells (F), which show a clear polarization in the direction of migration. The scale
bars represent 1 mm in (E), 50 mM in (E0), and 20 mm in (E00).and orientation. Indeed, all of these loops play a role in
the directional-migration inhibition caused by the C2 do-
main of PTEN (see Table S1).
To characterize further the inhibition of EMT and direc-
tional migration seen with these C-terminal polypeptides,
we investigated their effectsonPI3K-dependent signaling,
finding that expression of the PTEN C2 domain was also
found to cause a small but reproducible activation of
Akt/PKB in cultured cells lacking PTEN (Figure S8). We
also looked at the cellular localization of some of the
PTEN constructs used in this study and found that the full-
lengthC2domainand tail showedaverystrongmembrane
localization, which was strictly dependent on the PDZ
binding sequence (Figure S9). The C2 and tail construct
lacking this PDZ sequence did not show any significant
membrane localization and also lacked all inhibitory
activity on EMT. The PTEN-tail-only domain did not
show a clear membrane localization; instead, it even
showed some nuclear enrichment. The naked C2 domain
also does not show a very strong membrane localization.
These results suggest that both the C2 domain and the
PDZ binding site are necessary for efficient membrane
localization.Loss of Directional Cell Migration Caused
by the PTEN-Related Protein, TPTE,
Requires Phosphatase Activity
The PTEN-related protein, TPTE, is very similar in se-
quence to PTEN through the phosphatase and C2 do-
mains, but lacks a PDZ binding motif and an extensively
phosphorylated C-terminal tail. This suggested that we
might be able to use TPTE to address the mechanism
of action of PTEN in cell-migration assays because it is
the C-terminal tail that blocks cell migration out of the
primitive streak in this assay and may complicate the
analysis of the effects of PTEN by mediating phosphor-
ylation-dependent unfolding of the PTEN protein. We
found that although PTEN has robust activity against
phosphoinositides, a synthetic peptide [poly-Glu-Tyr(P)],
and an artificial substrate (pNPP), several preparations
of TPTE had no detectable activity against any of these
substrates (Figure S9, Figure 6, and [30]). Remarkably, it
proved possible to engineer a ‘‘reactivated’’ mutant of
TPTE (TPTE-R), in which a threonine and aspartic acid
in the phosphatase P loop were changed to residues
found in the corresponding positions in the active phos-
phatases TPIP and PTEN (Figure 6). Recombinant,
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121Figure 5. The PTEN C-Terminal Tail Is Sufficient to Block EMT, and the PTEN C2 Domain Is Able to Interfere with the Directional Migration of Cells
Escaping the Primitive Streak
(A) A schematic diagram of some of the PTEN mutants used in this study is shown. The CBR3 and Ca2 loop mutations comprise the replacement
of several exposed basic residues within these loops with alanine residues.
(B–I) Embryos were transfected with the mutant GFP-PTEN expression vectors, GFP-PTEN C2 + tail (B and C), GFP-PTEN C2 + tail DPDZ (D and
E), GFP-PTEN tail only (F and G), and GFP-PTEN C2 only (H and I). Initial (t = 0) and final (t = 20 hr) images are shown of the cell migration assay,
merging bright-field and fluorescent images, allowing the outward migration of green fluorescently marked cells to be observed.
(J–L) The effect of expression of GFP-PTEN tail only on EMT was investigated as described in Figure 2. Cells of the primitive streak were trans-
fected with vectors encoding GFP-PTEN tail only before grafting into an untransfected host embryo. Development and expression was allowed
to proceed for 20 hr before cell migration was assessed by low-power fluorescence microscopy (J), and cellular and tissue morphology were
analyzed by immunofluorescence microscopy at medium (K) and high (L) magnification (image sizes as described in Figure 2). The localization
of b-catenin is shown in the red channel and GFP-PTEN-tail-only expression in the green channel.bacterially expressed TPTE-R had robust activity
against both lipid and polypeptide substrates, which
when normalized for full-length protein content indicate
that the activities of PTEN and TPTE-R are very similar
(Figure 6). We were thus able to gain further insight
into the mechanism of action of PTEN in cell-migration
assays by making use of TPTE and TPTE-R. When ex-
pressed in the anterior primitive streak, GFP-TPTE did
not interfere with the directional migration of those cells
escaping the streak, whereas GFP-TPTE-R caused
strong random migration of these cells (Figures 6D and
6E). This indicates that the phosphatase activity of
TPTE-R causes aberrant directional migration of these
cells, in agreement with data implicating a role for
PtdIns(3,4,5)P3 in this process.
Discussion
Signaling through PI3 kinases and PtdIns(3,4,5)P3
has well-established and evolutionarily conservedsignificance in the directional regulation of cell migra-
tion, with evidence that PtdIns(3,4,5)P3 is concentrated
at the leading edge of many migrating cells [31, 32]
and the indication that in some experimental systems,
the PtdIns(3,4,5)P3 phosphatase activity of PTEN is re-
quired for the inhibition of migration by PTEN [6, 33].
However, it has also been suggested that the dominant
effect of PTEN on cell migration appears to act indepen-
dently of the PTEN enzymatic activity [5].
We have used mutagenesis to address the mecha-
nism of action by which PTEN expression inhibits cell
migration in the developing chick embryo. We have
found that overexpression of unfolded PTEN constructs
containing the C-terminal PDZ binding sequence result
in a strong inhibition of EMT. In the case of expression
of full-length PTEN, its protein phosphatase activity is
required for this inhibitory effect on EMT to be observed,
contributing to the evidence that this phosphatase ac-
tivity is required to expose the PDZ binding domain.
We do not yet know how the PTEN-tail PDZ sequence
Current Biology
122Figure 6. The PTEN-Related Protein TPTE Lacks Phosphatase Activity, but When Reactivated by Mutation Causes Aberrant Directional
Migration
(A) The TPTE protein-domain structure is shown, containing three N-terminal transmembrane domains, a phosphatase, and a C2 domain.
(B and C) The phosphatase activity of PTEN, TPTE, and the ‘‘reactivated’’ mutant TPTE-R against the lipid substrate PtdIns(3,4,5)P3 and the
phosphorylated peptide polymer polyGluTyr-P are shown. Data is shown as the mean labeled phosphate released from duplicate assays and
the range of these duplicates in dpm.
(D and E) Expression of GFP-TPTE (D) does not affect EMT or directed cell migration away from the streak, and the expression of the catalytically
active GFP-TPTE-R results in random migration of cells exiting the streak (E). Merged bright-field and fluorescence images for the start of the
experiment (t = 0) and the end (t = 20 hr) of the experiment are shown.exerts its inhibitory effect, but it seems likely that it acts
in a dominant-negative manner by inhibiting binding of
endogenous PTEN to sites at the plasma membrane
and that PTEN is required for the proper regulation of
EMT. An alternative explanation is that the PTEN-tail-
only domain inhibits the binding of another PDZ binding
protein, required for EMT, although we favor the former
hypothesis. Evidence suggests that PTEN may be re-
quired at adherens junctions for the dephosphorylation
of PtdIns(3,4,5)P3 and protein components such as cad-
herin and or a- and b-catenin in order to control the dis-
sociation of the cadherin/catenin complexes that is nec-
essary for EMT to occur [20, 21, 34, 35]. PTEN would
control these components’ phosphorylation state,
which is necessary for the stabilization of cell-cell junc-
tions, and inhibit EMT, thus explaining part of its action
as a tumor suppressor. Our results suggest that endog-
enous PTEN activity needs to be tightly regulated for
EMT to occur in a spatially and temporally coordinated
manner. Overexpression of PTEN (and possibly PTEN
G129E) would enhance the effects of endogenous
PTEN to suppress EMT. Displacement of endogenousPTEN by the tail-only domain would also prevent regula-
tion of these processes and potentially prevent EMT.
The experiments in which PTEN expression was
knocked down by RNAi are consistent with this pro-
posed model.
Interestingly, we found that overexpression of PTEN
was very effective in inhibiting EMT in anterior- and mid-
dle-primitive-streak cells but that there was very little
effect on EMT in posterior-primitive-streak cells. This
shows first of all that the inhibition is not due to some
nonspecific effect, but it also shows that the control of
EMT in the posterior streak must require a different
mechanism possibly involving other adhesion mole-
cules or internal adapter molecules.
The experiments in which PI3K was inhibited through
the use of PI3K inhibitors LY294002 and PI103 show
that high levels of PtdIns(3,4,5)P3 are not necessary for
EMT to occur. These experiments, however, did suggest
that PtdIns(3,4,5)P3 is critically involved in the direction-
ality of migration and that this is presumably through an
inhibition of the polarization of the cells in response to
factors that guide their migration. This is in line with
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lium, neutrophils and fibroblasts, where cells polarize
in response to cAMP, FMLP, and PDGF, respectively
[31]. The experiments with the PTEN DPDZ mutant are
in line with this observation. This mutant lacks the inhib-
itory effect on EMT, presumably because of a lack of
PDZ-binding-site-mediated targeting to sites required
for the regulation of EMT. Therefore, cells expressing
this mutant undergo EMT, and we could investigate the
effect of the PTEN on cell migration. These experiments
show that overexpression of PTEN DPDZ results in
random cell migration, whereas expression of PTEN
G129EDPDZ, which lacks the lipid phosphatase activity,
does not result in random cell migration. These findings
indicate that it is the lipid phosphatase activity of PTEN
that interferes with the directionality of cell migration
and that the protein phosphatase activity has no signifi-
cant effect on this property. Random cell migration is
also observed in the case of expression of TPTE-R. De-
spite its plasma-membrane localization, there is no sig-
nificant effect of TPTE on EMT, possibly because it is
not targeted to the correct sites in the membrane to
inhibit EMT. The lipid phosphatase activity, however,
should effectively modulate cellular PtdIns(3,4,5)P3
levels and could result in the inhibition of directional
migration. Although there is a good correlation between
the lipid phosphatase activity of the PTEN and TPTE
constructs used and their capacity to cause aberrant
directional migration, it is possible that this activity does
not directly block PI3K-dependent polarization and cell-
autonomous chemotaxis, but rather interferes with other
aspects of the complex migratory phenotype observed
in the developing embryo.
The C2 domain of PTEN from a variety of species is
able to inhibit directional cell migration in the absence
of phosphatase activity, resembling very much the phe-
notype observed after inhibition of PI3K. The finding that
expression of the PTEN C2 domain constructs in cul-
tured cells could activate Akt/PKB suggests that it is
possible that the C2 domain of PTEN directly interferes
with PI3K-dependent directional sensing through an
unknown mechanism, resulting in the observed random
migration. Random migration could be an explanation
for the effect of the C2 domain observed in the wound-
healing assay [5] because this will result in less efficient
migration into a scratch-wound area.
Several pieces of evidence indicate that TPTE lacks
significant phosphatase activity. TPTE is most similar
in sequence to, and evolutionarily appears to have arisen
from, the active phosphatases PTEN and TPIP (47% and
92% identity through the phosphatase domain, respec-
tively). In our experiments in which PTEN had good acti-
vity against three different substrates, TPTE lacked all
detectable activity. Strikingly, however, when TPTE was
mutated to have the same P loop sequence as PTEN
and TPIP, this mutant protein had strong phosphatase
activity against all three substrates. This strongly sug-
gests that these changes have occurred in the TPTE
sequence during evolution to produce a protein lacking
phosphatase activity, although the reason for this is
unclear.
In conclusion, it appears that PTEN may play a role in
two distinct processes controlling cell migration during
embryonic development. It seems to be critical for thecontrol of EMT. This action appears to require its protein
phosphatase activity, via both autodephosphorylation
to expose the tail domain and possibly also protein
phosphatase activity against other protein substrates.
Furthermore, through its lipid phosphatase activity, it
appears to be able to control cell polarization and di-
rectionality of mesodermal cell migration through the
regulation of cellular PtdIns(3,4,5)P3 levels. These two
actions may also be important in the development of
tumors that mostly arise in epithelia and then undergo
EMT before metastasis.
Experimental Procedures
Embryo Manipulation and Cell GFP Labeling
Brown Leghorn chick embryos (Henry Stewart, Lincolnshire) were
incubated at 37C in a tray-rocking incubator until they reached
HH 2–3 (Hamburger and Hamilton stage 2–3) [36]. New cultures
[37] and early chick (EC) cultures [38] were prepared, and trans-
fection was achieved by electroporation of 0.5 ml plasmid DNA at
a concentration of 1.0 mg/ml, microinjected into the space between
the vitellin membrane and the epiblast, next to the anterior primitive
streak, in HH2-3 embryos, by using a microinjector (FemtoJet,
Eppendorf). Embryos were electroporated by applications of two
successive 50 ms square pulses of 10 V through two parallel elec-
trodes, 1.5 mm apart, by using a custom-built electroporator (Iso-
lated Stimulator Model DS2, Digitimer, United Kingdom). After
electroporation, the embryos were further incubated at 38C for
3–5 hr, after which well-labeled GFP-positive primitive-streak tissue
from anterior, middle, or posterior region of the streak was grafted
into a host embryo of the same stage as the donor, from which an
equivalent piece of primitive streak was removed by using a tungsten
needle. The embryos were incubated at 38C for 1 hr, after which
they were photographed and time-lapse imaging was started. For
one-sided electroporation, the polarity of the pulses was kept
constant, whereas for electroporation of both sides of the embryo,
the polarity of the electrodes was switched between pulses.
Time-Lapse Imaging
Imaging of cell movement during early gastrulation was performed
as described previously [19]. Labeled embryos were incubated in
a custom-built microscope chamber, kept at 38C with water-satu-
rated heated air (AIR-THERMZ, serial: 54833-L048) and mounted on
a Zeiss Axiovert 100 inverted microscope with a plan-NEOFLUAR
2.53/0.075 objective (ZEISS) and Hamamatsu Orca-ER camera
[39]. Images were collected with Simple PCI software. Both bright-
field and fluorescence images were taken every 3 min. Cell-move-
ment tracks were generated by successive logical addition of
images with macros written with the Optimas VI imaging library. In
a typical experiment, we prepared two successful grafts starting
with around ten embryos; one embryo was chosen for filming, and
the remaining embryos were photographed at the beginning and
end of the experiment. Each experiment was repeated at least three
or four times (see Table S1).
Antibodies, Western Blotting, and Immunocytochemistry
Cell culture, lysis, western-blotting procedures, and assays of cellu-
lar Akt/PKB activity were as previously described [40]. DF1 chicken
fibroblasts were kindly provided by Cheryl Tickle (University of
Dundee). Antibodies against PTEN were purchased from Cascade
Bioscience (6H2.1 monoclonal, used for all studies of endogenous
cPTEN expression) and Santa Cruz (A2B1 monoclonal), and those
against PKB/Akt and E-Cadherin (L-CAM) were purchased from
Cell Signalling Technologies and the Developmental Studies Hybrid-
oma Bank (University of Iowa), respectively. Antibodies against
b-actin were from Sigma, and those raised against Glutathione
S-Transferase and GFP were kindly provided by James Hastie and
Hilary McLaughlin (Division of Signal Transduction Therapy, Dundee
University). For immunocytochemistry, chick embryos were fixed
overnight at 4C in 4% paraformadelhyde in PBS (pH 7.4) and
washed three times in PBS, followed by inactivation of endogenous
peroxidase by incubation with 0.3% H2O2 in PBS for 30 minutes.
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in PBT (2% Bovine Serum Albumin, 1% Triton-X; 1% Tween 20 in
PBS) for 1 hr at room temperature. The embryos were incubated in
anti-PTEN (6H2.1) at 1:100 in PBT overnight at 4C, followed by a fur-
ther overnight incubation in peroxidase-conjugated anti-mouse
(Promega) 1:1000 dilution. Anti-b-catenin (Sigma clone 15B8) was
used in a 1:100 dilution in PBT, followed by peroxidase anti-mouse
(1:1000 dilution). Detection was performed by using the tyramide-
signal-amplification system (Molecular Probes) with Alexa Fluor
555, according to the manufacturer’s instructions.
Supplemental Data
Supplemental Data include Experimental Procedures, ten figures,
one table, and one movie and are available with this article online
at: http://www.current-biology.com/cgi/content/full/17/2/115/DC1/.
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